Pestivirus control programs: how far have we come and where are we going?

被引:67
|
作者
Moennig, Volker [1 ]
Becher, Paul [1 ]
机构
[1] Univ Vet Med, Inst Virol, Dept Infect Dis, D-30559 Hannover, Germany
关键词
bovine viral diarrhea; classical swine fever; pestivirus control; BOVINE VIRAL DIARRHEA; CLASSICAL SWINE-FEVER; VIRUS BVDV INFECTIONS; ORAL IMMUNIZATION; FETAL PROTECTION; VACCINATION; CATTLE; VACCINES; DISEASE; ERADICATION;
D O I
10.1017/S1466252315000092
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Classical swine fever (CSF) is endemic in large parts of the world and it is a major threat to the pig industry in general. Vaccination and stamping out have been the most successful tools for the control and elimination of the disease. The systematic use of modified live vaccines (MLV), which are very efficacious and safe, has often preceded the elimination of CSF from regions or countries. Oral vaccination using MLV is a powerful tool for the elimination of CSF from wild boar populations. Bovine virus diarrhea (BVD) is endemic in bovine populations worldwide and programs for its control are only slowly gaining ground. With two genotypes BVD virus (BVDV) is genetically more diverse than CSF virus (CSFV). BVDV crosses the placenta of pregnant cattle resulting in the birth of persistently infected (PI) calves. PI animals shed enormous amounts of virus for the rest of their lives and they are the reservoir for the spread of BVDV in cattle populations. They are the main reason for the failure of conventional control strategies based on vaccination only. In Europe two different approaches for the successful control of BVD are being used: Elimination of PI animals without or with the optional use of vaccines, respectively.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [21] Catalyst: Aggregation-Induced Emission-How Far Have We Come, and Where Are We Going Next?
    Kenry
    Tang, Ben Zhong
    Liu, Bin
    CHEM, 2020, 6 (06): : 1195 - 1198
  • [22] Pancreatic cancer since halsted - How for have we come and where are we going?
    White, RR
    Shah, AS
    Tyler, DS
    ANNALS OF SURGERY, 2003, 238 (06) : S132 - S144
  • [23] Emergency medicine research: how far have we come and where are we heading?
    Yates, David W.
    Gray, Alasdair J.
    EMERGENCY MEDICINE JOURNAL, 2018, 35 (03) : 149 - 151
  • [24] Hip Arthroscopy: How Far We Have Come, and Where We Need to Go
    Spiker, Andrea M.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2024, 52 (13): : 3195 - 3197
  • [25] HOW FAR HAVE WE COME
    ROSENZWEIG, L
    AMERICAN JOURNAL OF MENTAL DEFICIENCY, 1959, 64 (01): : 12 - 18
  • [26] HOW FAR HAVE WE GOT IN PHARMAC ECONOMICS FOR PSYCHIATRY AND WHERE ARE WE GOING?
    McCrone, Paul
    Aitchison, Katherine
    Taylor, David
    CLINICAL NEUROPSYCHIATRY, 2008, 5 (04): : 173 - 174
  • [27] HOW FAR HAVE WE COME
    不详
    HUMAN ORGANIZATION, 1956, 15 (02) : 1 - 2
  • [28] HOW FAR HAVE WE COME
    HEIMLICH, HJ
    EMERGENCY MEDICAL SERVICES, 1982, 11 (01): : 82 - 83
  • [29] How far have we come?
    Robinson, Priscilla
    Kool, Bridget
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2015, 39 (06) : 505 - 505
  • [30] How far have we come?
    Crabtree, Robert H.
    DALTON TRANSACTIONS, 2013, 42 (12) : 4104 - 4104